ETF · holdings as filed 2026-06-30

What's inside IHE?

iShares U.S. Pharmaceuticals ETF
Holdings
59
positions in the fund
Top 10
75%
of fund assets
Expense ratio
0.38%
net, per year
Fund size
$1B
total net assets
Sectors tap a row to see its top 10 holdings
Top holdings — Health Care
Your 10 largest positions in this sector
1
J
JNJJOHNSON & JOHNSON
21.13%
2
L
LLYELI LILLY & CO
20.94%
3
M
MRKMERCK & CO. INC.
4.28%
4
B
BMYBRISTOL-MYERS SQUIBB CO
4.11%
5
R
RPRXROYALTY PHARMA PLC- CL A
4.08%
6
V
VTRSVIATRIS INC
3.97%
7
P
PFEPFIZER INC
3.73%
8
Z
ZTSZOETIS INC
3.51%
9
J
JAZZJAZZ PHARMACEUTICALS PLC
3.25%
10
E
ELANELANCO ANIMAL HEALTH INC
2.64%
Geography tap a row to see its top 10 holdings
Top holdings — United States
Your 10 largest positions in this country
1
J
JNJJOHNSON & JOHNSON
21.13%
2
L
LLYELI LILLY & CO
20.94%
3
B
BISXXBCF INSTITUTIONAL-SL AGNCY
5.88%
4
M
MRKMERCK & CO. INC.
4.28%
5
B
BMYBRISTOL-MYERS SQUIBB CO
4.11%
6
V
VTRSVIATRIS INC
3.97%
7
P
PFEPFIZER INC
3.73%
8
Z
ZTSZOETIS INC
3.51%
9
E
ELANELANCO ANIMAL HEALTH INC
2.64%
10
A
AXSMAXSOME THERAPEUTICS INC
2.27%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold IHE alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-06-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.